Company News

What Happens When You Stop Weight-Loss Medication? - Rightangled

What Happens When You Stop Weight-Loss Medication?

What a Major Study Found                                                                      ...

Read moreabout What Happens When You Stop Weight-Loss Medication?

mounjaroweight loss
Your Guide to the Mounjaro Changes in September 2025 - Rightangled

Your Guide to the Mounjaro Changes in September 2025

Important updates regarding everything Mounjaro. Understand the changes in September, and what you can expect from the Rightangled team in this time. From Pricing, to Stock Allocation, to Patient Care.

Read moreabout Your Guide to the Mounjaro Changes in September 2025

Debunking Common Myths About Weight Loss Medications - Part 1 - Rightangled

Debunking Common Myths About Weight Loss Medications - Part 1

  Obesity is a chronic disease and a significant global public health issue. It is associated with increased morbidity and mortality and can significantly reduce life expectancy. Research indicates that individuals with a BMI of 40 kg/m² or higher may...

Read moreabout Debunking Common Myths About Weight Loss Medications - Part 1

FAQsGIPGLP-1mounjarowegovyweight loss
Navigating GLP-1 Medications: Ultimate Guide for the community - Rightangled

Navigating GLP-1 Medications: Ultimate Guide for the community

Dr Sohaib Imtiaz our Clinical Lead and Board certified Lifestyle Medicine Doctor went live with our community. Here are some of the questions we were asked.  As the landscape of weight management medications evolves, questions arise about specific drugs, their...

Read moreabout Navigating GLP-1 Medications: Ultimate Guide for the community

Investor
Shareholders' letter | Year end 2021 updates - Rightangled

Shareholders' letter | Year end 2021 updates

The copy of an email newsletter sent by CEO Abdullah Sabyah to Rightangled investors on Christmas day (25th of December 2021), the letter covers a full overview and updates from the year-end 2021 with a business outlook to the year 2022.

Read moreabout Shareholders' letter | Year end 2021 updates

Rightangled: Changing the Way We Look at DNA - Rightangled

Rightangled: Changing the Way We Look at DNA

According to the World Health Organisation, cardiovascular diseases (CVD) are the leading cause of deaths worldwide. An estimated 17.7 million people died from CVDs in 2015, representing 31% of all global deaths. In the UK alone, 7 million people battle with CVDs every day. Rightangled...

Read moreabout Rightangled: Changing the Way We Look at DNA

News
Rightangled Hits Crowdcube’s £500K Funding Cap! - Rightangled

Rightangled Hits Crowdcube’s £500K Funding Cap!

Rightangled the award-Winning Health Tech company regulated by the Care Quality Commission (CQC), is delighted to announce the success of its recent crowdfunding campaign, created to generate working capital needed to fulfil unprecedented corporate demand for its COVID-19 testing kits....

Read moreabout Rightangled Hits Crowdcube’s £500K Funding Cap!

Rightangled Launches COVID-19 Test - Rightangled

Rightangled Launches COVID-19 Test

FOR IMMEDIATE RELEASE: 25th of March 2020 Louise Brettell Rightangled Limited +44 203950 3394 louise@rightangled.co     Rightangled Launches COVID-19 Test Home-based COVID-19 Test, with 50% subsidised cost for NHS frontline staff     London, Greater London: Rightangled Limited, on...

Read moreabout Rightangled Launches COVID-19 Test

News
Presenting G-Fit: The First-Ever Genotype-Based Fitness Class - Rightangled

Presenting G-Fit: The First-Ever Genotype-Based Fitness Class

‍ We are excited to announce the launch of our new genotype-based “G-Fit” fitness class concept, focusing on tailor-made exercises to accommodate different muscle types. ‍   This means that, for the first time, DNA testing isn’t just about giving...

Read moreabout Presenting G-Fit: The First-Ever Genotype-Based Fitness Class